Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Horm Behav ; 161: 105516, 2024 May.
Article in English | MEDLINE | ID: mdl-38428223

ABSTRACT

Studies in ovariectomized (OVX) female rodents suggest that G protein-coupled estrogen receptor (GPER) is a key regulator of memory, yet little is known about its importance to memory in males or the cellular mechanisms underlying its mnemonic effects in either sex. In OVX mice, bilateral infusion of the GPER agonist G-1 into the dorsal hippocampus (DH) enhances object recognition and spatial memory consolidation in a manner dependent on rapid activation of c-Jun N-terminal kinase (JNK) signaling, cofilin phosphorylation, and actin polymerization in the DH. However, the effects of GPER on memory consolidation and DH cell signaling in males are unknown. Thus, the present study first assessed effects of DH infusion of G-1 or the GPER antagonist G-15 on object recognition and spatial memory consolidation in gonadectomized (GDX) male mice. As in OVX mice, immediate post-training bilateral DH infusion of G-1 enhanced, whereas G-15 impaired, memory consolidation in the object recognition and object placement tasks. However, G-1 did not increase levels of phosphorylated JNK (p46, p54) or cofilin in the DH 5, 15, or 30 min after infusion, nor did it affect phosphorylation of ERK (p42, p44), PI3K, or Akt. Levels of phospho-cAMP-responsive element binding protein (CREB) were elevated in the DH 30 min following G-1 infusion, indicating that GPER in males activates a yet unknown signaling mechanism that triggers CREB-mediated gene transcription. Our findings show for the first time that GPER in the DH regulates memory consolidation in males and suggests sex differences in underlying signaling mechanisms.


Subject(s)
Hippocampus , Memory Consolidation , Quinolines , Receptors, G-Protein-Coupled , Signal Transduction , Animals , Male , Memory Consolidation/physiology , Memory Consolidation/drug effects , Female , Mice , Hippocampus/metabolism , Hippocampus/drug effects , Receptors, G-Protein-Coupled/metabolism , Signal Transduction/physiology , Signal Transduction/drug effects , Receptors, Estrogen/metabolism , Ovariectomy , Orchiectomy , Cyclopentanes/pharmacology , Cyclic AMP Response Element-Binding Protein/metabolism , Mice, Inbred C57BL
2.
Life Sci ; 263: 118593, 2020 Dec 15.
Article in English | MEDLINE | ID: mdl-33069738

ABSTRACT

AIM: This study set forth a question: are there any differences in bone responses to insulin and/or vitamin D3 treatment in female and male type 1 diabetic (T1D) mice? MAIN METHODS: To address this issue, a non-critical sized femur defect was created in streptozotocin (STZ)-T1D mice. Control non-diabetic and T1D female and male mice received: saline; vitamin D3; insulin; or vitamin D3 plus insulin, for 21 days. KEY FINDINGS: Female and male T1D mice showed impaired bone healing, as indicated by histological and micro-computed tomography (micro-CT) analysis. Vitamin D3 or insulin improved the bone regeneration in T1D mice, irrespective of sex. Vitamin D3 plus insulin did not exhibit any additional effects. There were no differences regarding the numbers of TRAP-stained osteoclasts in either evaluated groups. The osteoblast-related gene osterix was upregulated in vitamin D3-treated male T1D mice, as revealed by RT-qPCR. Female T1D mice treated with vitamin D3, insulin, or vitamin D3 plus insulin presented an increased expression of insulin growth factor-1 (IGF-1) mRNA. Conversely, IGF-1 mRNA levels were reduced by the same treatments in male TD1 mice. SIGNIFICANCE: Altogether, the results suggested that T1D similarly delayed the osseous healing in female and male mice, with beneficial effects for either vitamin D3 or insulin in T1D mice of both sexes. However, data indicated marked sex differences regarding the expression of genes implicated in bone formation, in T1D mice treated with vitamin D3 and/or insulin.


Subject(s)
Bone Regeneration/drug effects , Cholecalciferol/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Insulin/pharmacology , Animals , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Type 1/complications , Female , Gene Expression Regulation , Insulin-Like Growth Factor I/genetics , Male , Mice , Mice, Inbred C57BL , Osteoclasts/metabolism , Osteogenesis/drug effects , Osteogenesis/genetics , Sex Factors , Streptozocin , X-Ray Microtomography
3.
J Neurosci ; 35(49): 16272-81, 2015 Dec 09.
Article in English | MEDLINE | ID: mdl-26658875

ABSTRACT

The gastrin-releasing peptide (GRP) and its receptor (GRPR) are important components of itch transmission. Upstream, but not downstream, aspects of GRPR signaling have been investigated extensively. We hypothesize that GRPR signals in part through the PI3Kγ/Akt pathway. We used pharmacological, electrophysiological, and behavioral approaches to further evaluate GRPR downstream signaling pathways. Our data show that GRP directly activates small-size capsaicin-sensitive DRG neurons, an effect that translates into transient calcium flux and membrane depolarization (∼ 20 mV). GRPR activation also induces Akt phosphorylation, a proxy for PI3Kγ activity, in ex vivo naive mouse spinal cords and in GRPR transiently expressing HEK293 cells. The intrathecal injection of GRP led to intense scratching, an effect largely reduced by either GRPR antagonists or PI3Kγ inhibitor. Scratching behavior was also induced by the intrathecal injection of an Akt activator. In a dry skin model of itch, we show that GRPR blockade or PI3Kγ inhibition reversed the scratching behavior. Altogether, these findings are highly suggestive that GRPR is expressed by the central terminals of DRG nociceptive afferents, which transmit itch via the PI3Kγ/Akt pathway. SIGNIFICANCE STATEMENT: Itch is the most common symptom of the skin and is related to noncutaneous diseases. It severely impairs patients' quality of life when it becomes chronic and there is no specific or effective available therapy, mainly because itch pathophysiology is not completely elucidated. Our findings indicate that the enzyme PI3Kγ is a key central mediator of itch transmission. Therefore, we suggest PI3Kγ as an attractive target for the development of new anti-pruritic drugs. With this study, we take a step forward in our understanding of the mechanisms underlying the central transmission of itch sensation.


Subject(s)
Central Nervous System/metabolism , Gastrin-Releasing Peptide/metabolism , Phosphatidylinositol 3-Kinase/metabolism , Pruritus/pathology , Receptors, Bombesin/metabolism , Synaptic Transmission/physiology , Action Potentials/drug effects , Animals , Anticarcinogenic Agents/therapeutic use , Bombesin/analogs & derivatives , Bombesin/therapeutic use , Capsaicin/toxicity , Central Nervous System/drug effects , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Ganglia, Spinal/cytology , Indoles/pharmacology , Male , Mice , Neurons/drug effects , Neurons/physiology , Pain Threshold/drug effects , Peptide Fragments/therapeutic use , Pruritus/chemically induced , Pruritus/complications , Pruritus/drug therapy , Quinoxalines/pharmacology , Reaction Time/physiology , Synaptic Transmission/drug effects , Thiazolidinediones/pharmacology , p-Methoxy-N-methylphenethylamine/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...